Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_assertion type Assertion NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_head.
- NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_assertion description "[Taken together, our data strongly suggest that CHK is capable of inhibiting the CXCL12-CXCR4 pathway in neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_provenance.
- NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_assertion evidence source_evidence_literature NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_provenance.
- NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_assertion SIO_000772 18292939 NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_provenance.
- NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_assertion wasDerivedFrom befree-20140225 NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_provenance.
- NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_assertion wasGeneratedBy ECO_0000203 NP186130.RAdl-BWv6R8uQ87LvsIGCBCELafwB4puwMtpBJpBjxOAk130_provenance.